. Astrocytes are one of the predominant cell types in the brain. In AD they are activated and produce inflammatory components such as complement components, acute phase proteins, and cytokines. In this study we analyzed the effect of cytokines on the production of amyloid ␤ (A␤) in the astrocytoma cell line U373 and in primary human astrocytes isolated postmortem from healthy aged persons as well as from patients with AD. Astrocytes did not produce A␤ in the absence of stimuli or following stimulation with IL-1␤, TNF␣, IL-6, and TGF-␤1. Neither did combinations of TNF␣ and IL-1␤, IL-6 or TGF-␤1, or the coadministration of IFN␥ and IL-6 or TGF-␤1 induce A␤ production. In contrast, pronounced production of A␤1-40 and A␤1-42 was observed when primary astrocytes or astrocytoma cells were stimulated with combinations of IFN␥ and TNF␣ or IFN␥ and IL-1␤. Induction of A␤ production was accompanied by decreased glycosylation of APP as well as by increased secretion of APPs␤. Our results suggest that astrocytes may be an important source of A␤ in the presence of certain combinations of inflammatory cytokines. IFN␥ in combination with TNF␣ or IL-1␤ seems to trigger A␤ production by supporting ␤-secretase cleavage of the immature APP molecule.
INTRODUCTION
Astrocytes are resident brain cells that do not only play an important role by maintaining brain structures, but can influence the course of neurological diseases (Levine, 1999) . There are a number of stimuli that lead to astrocyte activation. Neuronal dysfunction or injury have been shown to be of particular relevance (Ni, 1997) . Upon traumatic brain injury rapid and vigorous activation of astrocytes and microglial cell activation take place. This response is transient and reversible. In contrast, in a number of chronic diseases, including Alzheimer's disease (AD), glial cells remain in a permanent state of activation. Several lines of evidence suggest that amyloid beta (A␤) can activate astrocytes (Hu, 1998; Johnstone, 1999) and that the inflammatory response induced upon glial activation is a critical component in this neurodegenerative disorder (McGeer, 1995) . Little attention has so far been paid to the question whether astrocytes can also participate in the fundamental pathology of AD by producing A␤. As astrocytosis is one of the characteristic features in the AD-brain, A␤ production by astrocytes (LeBlanc, 1997) may substantially contribute to the A␤ load.
As activated astrocytes can produce Interleukin-1␤ (IL-1␤), tumor necrosis factor alpha (TNF␣), interleu-
